Back to LXRX
Fortitude Family Office, LLC → LXRX
Fortitude Family Office, LLC LXRX Position History
Lexicon Pharmaceuticals, Inc.
Quarters held
5
Latest value
$1K
Q3 2026
Peak value
$2K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $953 |
| Q4 2025 | $812 |
| Q1 2026 | $1K |
| Q2 2026 | $2K |
| Q3 2026 | $1K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1K | 706 | — | — |
| Q2 2026 | $2K | 706 | — | — |
| Q1 2026 | $1K | 706 | — | — |
| Q4 2025 | $812 | 706 | — | — |
| Q3 2025 | $953 | 706 | — | — |
Other funds holding LXRX
Other Fortitude Family Office, LLC positions
ETHA
$50.9MISHARES CORE S&P 500 ETF
ETHA
$46.4MISHARES CORE S&P 500 ETF
VGES
$37.3MVANGUARD 0-3 MONTH TREASURY BILL ETF
ETHA
$36.4MISHARES CORE S&P 500 ETF
ETHA
$34.7MISHARES CORE S&P 500 ETF
ETHA
$33MISHARES CORE S&P 500 ETF
ETHA
$30.4MISHARES CORE MSCI INTERNATIONAL DEVELOPED MARKETS ETF
VGES
$29.8MVANGUARD 0-3 MONTH TREASURY BILL ETF